Stock Market LIVE updates: Over 400 stocks hit upper circuit in listless session; 318 at 52-wk high
Stock Market LIVE updates on Wednesday, August 21: Interarch Building IPO, meanwhile, has been subscribed over 28x so far on the last day of the bidding
 "BSE, NSE, Indian share market, Stock market")
Stock Market LIVE on Wednesday, August 21, 2024: Key indices across the Indian stock markets were trading in a narrow range on Wednesday.
The BSE Sensex was down 50 points at 80,750 levels, while Nifty50 was up 28 points at 24,728 levels.
The BSE Sensex was down 50 points at 80,750 levels, while Nifty50 was up 28 points at 24,728 levels.
Divi's Labs, Titan Company, Hindalco, HDFC Life, SBI Life, Dr REddy's Labs, and Cipla were the top gainers in the large-cap universe, while Ultratech Cement, Tata Steel, HDFC Bank, Tech M, SBI, and ICICI Bank were the top laggards.
Broader markets, on the other hand, were trading with a positive bias. Nifty SmallCap rose 1 per cent while MidCap was trading 0.21 per cent higher.
Sectorally, the Nifty FMCG, and Media were leading with over 1 per cent gains, while IT, Banks, and Realty indices traded up to 1.45 per cent lower.
3:17 PM 
![]()
MCX, Lupin, TechM, Trent among 5 F&O stocks to Buy ahead of August expiry
As we near the expiry for the August month (29-August) derivatives, the stocks tend to get influenced by the open positions in the futures and options side of trade. READ MORE
3:14 PM
TaMo ties up with two firms to expand charging infra for electric CVs
Tata Motors on Wednesday said it has tied up with Delta Electronics India and Thunderplus Solutions to set up charging infrastructure for its range of electric commercial vehicles (CVs). As part of the MoU inked between the parties, 250 new fast-charging stations for electric commercial vehicles would be set up across the country. READ MORE
3:10 PM![]()
Alphabet-backed NBFC Aye Finance to launch Rs 2k cr IPO in a year: Report
Aye Finance, a non-bank financial company, is targeting to launch its initial public offering (IPO) within the next nine to 12 months, according to a report by MoneyControl. The Alphabet-backed company, which focuses on small and medium enterprises (SMEs), has enlisted four arrangers for its forthcoming IPO. Aye Finance aims to raise between Rs 1,700 and 2,000 crore in capital through the offering. READ MORE
2:55 PM![]()
FPIs yanked out $1.8bn from financial stocks amid global risk off
On August 5, FPIs sold shares worth Rs 10,073 crore, marking their third-largest single-day outflow, which led to a 3 per cent drop in benchmark indices. READ MORE
2:39 PM ![]()
This Aditya Birla Group stock has zoomed 60% in 4 weeks; up 115% since April
Shares of Century Enka hit a record high of Rs 863.90, as they surged 12% on the BSE in Wednesday's intra-day trade in an otherwise range-bound market. READ MORE
2:26 PM 
![]()
ALERT:: Range-bound Nifty holds 24,700 level, up 37 pts
2:14 PM![]()
This Mukul Agrawal-owned smallcap stock has zoomed 57% in 4 days
Shares of Tasty Bite Eatables continued at their upward movement for the fourth straight day, hitting seven-month high of Rs 15,222.90, surging 20% on the BSE in Wednesday's intra-day trade. READ MORE
2:02 PM![]()
Indoco Remedies stock soars over 5% on USFDA approval for opioids drug
Indoco Remedies stock surged up to 5.53 per cent at Rs 358.60 per share on the BSE in Wednesday’s intraday deals. This came after the company disclosed that it has received a final approval from the United States Food and Drugs Administration (USFDA) for its new drug application. READ MORE
1:38 PM ![]()
Updater Services stock surges 11% on acquiring stake in subsidiary; details
Updater Services shares surged up to 10.6 per cent at Rs 358.60 per share on the BSE in Wednesday’s intraday deals. This came after the company acquired an additional 22.3 per cent stake in Denave India for Rs 52.57 crore on Tuesday. READ MORE
1:25 PM![]()
Rane Group stocks rally; Rane (Madras), Rane Engine, Rane Brake zoom 20%
Shares of Rane Group companies -- Rane (Madras) (Rs 1,320.60), Rane Engine Valve (Rs 518.25), and Rane Brake Lining (Rs 1,197.10) -- were on a roll on Wednesday. The group stocks zoomed 20 per cent on the BSE in the intraday trade in an otherwise subdued market. READ MORE
1:10 PM 
![]()
F&O Insights: FIIs cover shorts in Bank Nifty; 24,600 is the key for Nifty
The Nifty futures rose by 0.4 per cent on Tuesday to 24,711. The August month futures premium further dipped to Rs 12.25 points to 22.75 a day earlier amid lower market volatility. Trading volumes were below average, with around 1.50 lakh contracts traded on Wednesday as against the last 7-day average volume of around 2.63 lakh contracts. READ MORE
12:55 PM![]()
Larsen & Toubro bags 'large' order for infra development in Maharashtra
Engineering and construction conglomerate Larsen & Toubro (L&T) on Wednesday said that it has bagged a 'large' order for integrated infrastructure development in Maharashtra. The order has been bagged by the Transportation Infrastructure vertical of L&T, the company said in a stock exchange filing. READ MORE
12:41 PM 
Pfizer surges 3% as investors cheer 350% dividend announcement; details
Shares of pharmaceutical company Pfizer jumped as much as 3 percent to Rs 6,068.10 during intra-day trade on Wednesday. The northward movement in the rally follows the announcement of a whopping 350 per cent dividend, or Rs 35 per share, for FY24. READ MORE
12:35 PM![]()
Here's why Marksans Pharma stocks hit 52-week high on August 21; Know more
Shares of pharmaceutical company Marksans Pharma rose as much as 1.83 per cent to hit a fresh 52-week high of Rs 224.95 per share. The surge in the stock price came after the company announced that its wholly owned subsidiary (WOS) Relonchem Limited has secured Marketing Authorisation from Medicines and Healthcare products Regulatory Agency (UKMHRA) for three products including Fluoxetine 10 mg Capsules; Fluoxetine 30 mg Capsules; Fluoxetine 60 mg Capsules. READ MORE
12:20 PM 
![]()
Divi's Labs shares jump 5% as US court stays FDA approval for Entresto drug
Shares of Divi’s Laboratories surged up to 5 per cent at Rs 4960 per share on the BSE in Wednesday’s intraday deals. This came after a US court stayed the United States Food and Drugs Administration (USFDA) approval given to a generic drug version of Novartis AG’s heart failure drug, according to a Bloomberg report. READ MORE
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 21 2024 | 7:39 AM IST
